Counterfeit medicines, a threat to public health!

The considerable rise in incidences directly related to the counterfeiting of prescription medicines and the associated threat to public health over the past 3 years has been a major factor in Merck & Co., Inc. (known as Merck MSD in Europe) dedicating increased resources to preventing and detecting counterfeits and counterfeiting operations worldwide. Globalisation and the Internet have led to greatly increased volumes of international trade and, unfortunately, have also presented opportunities for dishonest and unscrupulous criminals and traders to exploit the system.